Publications

  1. Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc. 2014 Apr; 89(4):484-92. Epub 2014 Feb 26.
    View PubMed
  2. Kenderian SS, Al-Kali A, Gangat N, Letendre L, Hogan WJ, Litzow MR, Patnaik MM. Monosomal karyotype in Philadelphia chromosome-negative acute lymphoblastic leukemia. Blood Cancer J. 2013; 3:e122. Epub 2013 Jul 05.
    View PubMed
  3. Lim MY, Al-Kali A, Ashrani AA, Begna KH, Elliott MA, Hogan WJ, Hook CC, Kaufmann SH, Letendre L, Litzow MR, Patnaik MS, Pardanani A, Tefferi A, Wolanskyj AP, Grill DE, Pruthi RK. Comparison of complication rates of Hickman((R)) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy. Leuk Lymphoma. 2013 Jun; 54(6):1263-7. Epub 2012 Nov 19.
    View PubMed
  4. Elliott MA, Letendre L, Tefferi A, Hogan WJ, Hook C, Kaufmann SH, Pruthi RK, Pardanani A, Begna KH, Ashrani AA, Wolanskyj AP, Al-Kali A, Litzow MR. Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy. Eur J Haematol. 2012 Mar; 88(3):237-43. Epub 2011 Nov 17.
    View PubMed
  5. Tefferi A, Letendre L. Nilotinib treatment-associated peripheral artery disease and sudden death: yet another reason to stick to imatinib as front-line therapy for chronic myelogenous leukemia. Am J Hematol. 2011 Jul; 86(7):610-1. Epub 2011 May 31.
    View PubMed
  6. Balin SJ, Wetter DA, Kurtin PJ, Letendre L, Pittelkow MR. Myelodysplastic syndrome presenting as generalized granulomatous dermatitis. Arch Dermatol. 2011 Mar; 147(3):331-5.
    View PubMed
  7. Elliott MA, Letendre L, Gastineau DA, Winters JL, Pruthi RK, Heit JA. Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic consideration. Eur J Haematol. 2010 Jul; 85(1):43-50. Epub 2010 Mar 20.
    View PubMed
  8. Elliott MA, Litzow MR, Letendre LL, Wolf RC, Hanson CA, Tefferi A, Tallman MS. Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival. Blood. 2007 Dec 15; 110(13):4172-4. Epub 2007 Oct 01.
    View PubMed
  9. Elliott MA, Tefferi A, Hogan WJ, Letendre L, Gastineau DA, Ansell SM, Dispenzieri A, Gertz MA, Hayman SR, Inwards DJ, Lacy MQ, Micallef IN, Porrata LF, Litzow MR. Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia. Bone Marrow Transplant. 2006 Jun; 37(11):1003-8.
    View PubMed
  10. Behl D, Porrata LF, Markovic SN, Letendre L, Pruthi RK, Hook CC, Tefferi A, Elliot MA, Kaufmann SH, Mesa RA, Litzow MR. Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia. Leukemia. 2006 Jan; 20(1):29-34.
    View PubMed
  11. Litzow MR, Dietz AB, Bulur PA, Butler GW, Gastineau DA, Hoering A, Fink SR, Letendre L, Padley DJ, Paternoster SF, Tefferi A, Vuk-Pavlovic S. Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML. Cytotherapy. 2006; 8(3):290-8.
    View PubMed
  12. Kaufmann SH, Karp JE, Letendre L, Kottke TJ, Safgren S, Greer J, Gojo I, Atherton P, Svingen PA, Loegering DA, Litzow MR, Sloan JA, Reid JM, Ames MM, Adjei AA, Erlichman C. Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemia. Clin Cancer Res. 2005 Sep 15; 11(18):6641-9.
    View PubMed
  13. Chen YC, Chou JM, Letendre L, Li CY. Clinical importance of bone marrow monocytic nodules in patients with myelodysplasia: Retrospective analysis of 21 cases. Am J Hematol. 2005 Aug; 79(4):329-31.
    View PubMed
  14. Gore SD, Smith BD, Gojo I, Grever M, Kaufmann SH, Letendre L, Leonard DGB, Marcucci G, Miller CB, Morris L, Piantadosi S, Prior T, Stock W, Karp JE. Durable molecular remissions with a single cycle of timed sequential consolidation chemotherapy in acute promyelocytic leukemia. Am J Hematol. 2005 Jun; 79(2):119-27.
    View PubMed
  15. Elliott MA, Wolf RC, Hook CC, Pruthi RK, Heit JA, Letendre LL, Tefferi A, Kaufmann SH, Mesa RA, Litzow MR. Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: Incidence, risk factors, and possible role of antithrombin. Leukemia & Lymphoma. 2004 Aug; 45(8):1545-9.
    View PubMed
  16. Greenberg PL, Lee SJ, Advani R, Tallman MS, Sikic BI, Letendre L, Dugan K, Lum B, Chin DL, Dewald G, Paietta E, Bennett JM, Rowe JM. Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: A phase III trial (E2995). J Clin Oncol. 2004 Mar 15; 22(6):1078-86.
    View PubMed
  17. Chen YC, Chou JM, Ketterling RP, Letendre L, Li CY. Histologic and immunohistochemical study of bone marrow monocytic nodules in 21 cases with myelodysplasia. Am J Clin Pathol. 2003 Dec; 120(6):874-81.
    View PubMed
  18. Litzow MR, Repoussis PD, Schroeder G, Schembri-Wismayer D, Batts KP, Anderson PM, Arndt CA, Chen MG, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, Tefferi A, Noel P, Solberg LA Jr, Letendre L, Hoagland HC. Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator. Leuk Lymphoma. 2002 Nov; 43(11):2099-107.
    View PubMed
  19. Hogan WJ, Letendre L, Litzow MR, Tefferi A, Hoagland HC, Pruthi RK, Kaufmann SH. Neutropenic colitis after treatment of acute myelogenous leukemia with idarubicin and cytosine arabinoside. Mayo Clin Proc. 2002 Aug; 77(8):760-2.
    View PubMed
  20. Porrata LF, Litzow MR, Tefferi A, Letendre L, Kumar S, Geyer SM, Markovic SN. Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia. 2002 Jul; 16(7):1311-8.
    View PubMed
  21. Elliott MA, Letendre L, Hanson CA, Tefferi A, Dewald GW. The prognostic significance of trisomy 8 in patients with acute myeloid leukemia. Leuk Lymphoma. 2002 Mar; 43(3):583-6.
    View PubMed
  22. Tack DK, Letendre L, Kamath PS, Tefferi A. Development of hepatic veno-occlusive disease after Mylotarg infusion for relapsed acute myeloid leukemia. Bone Marrow Transplant. 2001 Nov; 28(9):895-7.
    View PubMed
  23. Steensma DP, Hanson CA, Letendre L, Tefferi A. Myelodysplasia with fibrosis: a distinct entity? Leuk Res. 2001 Oct; 25(10):829-38.
    View PubMed
  24. Greenlund LJS, Letendre L, Tefferi A. Acute leukemia during pregnancy: a single institutional experience with 17 cases. Leuk Lymphoma. 2001 May; 41(5-6):571-577.
    View PubMed
  25. Tefferi A, Elliott MA, Steensma DP, Hook CC, Dispenzieria A, Hanson CA, Schroeder G, Letendre L. Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome. Leuk Res. 2001 Feb; 25(2):183-5.
    View PubMed
  26. Robles C, Kim KM, Oken MM, Bennett JM, Letendre L, Wiernik PH, O'Connell MJ, Cassileth PA. Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483). Leukemia. 2000 Aug; 14(8):1349-53.
    View PubMed
  27. van Der Vliet HJ, Roberson AE, Hogan MC, Morales CE, Crader SC, Letendre L, Pruthi RK. All-trans-retinoic acid-induced myositis: a description of two patients. Am J Hematol. 2000 Feb; 63(2):94-8.
    View PubMed
  28. Letendre L, Noel P, White WL, Tefferi A, Litzow MR, Li CY, Schroeder G. Treatment of unfavorable myelodysplastic syndrome with all-trans-retinoic acid and subcutaneous Ara C. Leuk Res. 1999 Sep; 23(9):811-5.
    View PubMed
  29. Elliott MA, Letendre L, Li CY, Hoyer JD, Hammack JE. Chronic lymphocytic leukaemia with symptomatic diffuse central nervous system infiltration responding to therapy with systemic fludarabine. Br J Haematol. 1999 Mar; 104(4):689-94.
    View PubMed
  30. Mongkonsritragoon W, Letendre L, Li CY. Multiple lymphoid nodules in bone marrow have the same clonality as underlying myelodysplastic syndrome recognized with fluorescent in situ hybridization technique. Am J Hematol. 1998 Nov; 59(3):252-7.
    View PubMed
  31. Mongkonsritragoon W, Letendre L, Qian J, Li CY. Nodular lesions of monocytic component in myelodysplastic syndrome. Am J Clin Pathol. 1998 Aug; 110(2):154-62.
    View PubMed
  32. Letendre L, Noel P, Litzow MR, Hoagland HC, Tefferi A. Treatment of acute myelogenous leukemia in the older patient with attenuated high-dose ara-C. Am J Clin Oncol. 1998 Apr; 21(2):142-4.
    View PubMed
  33. Letendre L, Moore SB. Successful pregnancy after conditioning with cyclophosphamide and fractionated total body irradiation. Med Pediatr Oncol. 1997 Feb; 28(2):147-8.
    View PubMed
  34. Kaufmann SH, Gore SD, Letendre L, Svingen PA, Kottke T, Buckwalter CA, Jones RJ, Grochow LB, Burke PJ, Donehower RC, Rowinsky EK. Factors affecting topotecan sensitivity in human leukemia samples. Ann N Y Acad Sci. 1996 Dec 13; 803:128-42.
    View PubMed
  35. Letendre L, Noel P, Tefferi A, Solberg LA Jr, Gastineau DA, Hoagland HC. Continuous infusion etoposide/carboplatin for treatment of refractory acute leukemia. Am J Clin Oncol. 1995 Oct; 18(5):382-4.
    View PubMed
  36. Witzig TE, Letendre L, Gerstner J, Schroeder G, Mailliard JA, Colon-Otero G, Marschke RF, Windschitl HE. Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial. J Clin Oncol. 1995 Aug; 13(8):2012-5.
    View PubMed
  37. Letendre L, Levitt R, Pierre RV, Schroeder G, Krook JA, Mailliard JE, Morton RF, Tschetter LK. Myelodysplastic syndrome treatment with danazol and cis-retinoic acid. Am J Hematol. 1995 Apr; 48(4):233-6.
    View PubMed
  38. Gertz MA, Pineda AA, Chen MG, Letendre L, Greipp PR, Solberg LA Jr, Witzig TE, Garton JP, Inwards DJ, Litzow MR, et al. Refractory and relapsing multiple myeloma treated by blood stem cell transplantation. Am J Med Sci. 1995 Mar; 309(3):152-61.
    View PubMed
  39. Letendre L, Hoagland HC, Moore SB, Chen MG, Gastineau DA, Gertz MA, Habermann TM, Litzow MR, Noel P, Solberg LA Jr, et al. Mayo Clinic experience with allogeneic and syngeneic bone marrow transplantation, 1982 through 1990. Mayo Clin Proc. 1992 Feb; 67(2):109-16.
    View PubMed
  40. Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG. Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc. 1992 Feb; 67(2):117-22.
    View PubMed
  41. Letendre L, Hoagland HC, Gertz MA. Hemorrhagic cystitis complicating bone marrow transplantation. Mayo Clin Proc. 1992 Feb; 67(2):128-30.
    View PubMed
  42. Graham DL, Tefferi A, Letendre L, Gastineau DA, Hoagland HC, Noel P. Cytogenetic and molecular detection of residual leukemic cells after allogeneic bone marrow transplantation in chronic granulocytic leukemia. Mayo Clin Proc. 1992 Feb; 67(2):123-7.
    View PubMed
  43. Brecher ME, Moore SB, Letendre L. Posttransfusion purpura: the therapeutic value of p1-a1-negative platelets. Transfusion (Paris) 1990 Jun; 30:433-435.
    View PubMed
  44. Lust JA, Letendre L, Thibodeau SN. Marrow hypoplasia associated with a monoclonal CD8 large granular lymphocyte proliferation: reversal with cyclophosphamide and prednisone. Am J Med. 1989 Aug; 87(2):214-7.
    View PubMed
  45. Letendre L. Treatment of lymphomatoid granulomatosis: old and new perspectives. Semin Respir Med. 1989 Apr; 10:178-181.
  46. Letendre L, Niedringhaus RD, Therneau TM, Gastineau DA, Goldberg RM, Gerstner JB, Mailliard JA, Gundlach WJ, Kardinal CG, Pierre RV. Treatment of acute nonlymphocytic leukemia in the elderly with intermediate high-dose cytosine arabinoside. Med Pediatr Oncol. 1989; 17(2):79-82.
    View PubMed
  47. Diez-Martin JL, Habermann TM, Gastineau DA, Solberg LA Jr, Letendre L. Nonbacterial thrombotic endocarditis in autologous bone marrow transplantation. Am J Med. 1988 Nov; 85(5):742-4.
    View PubMed
  48. Kriegshauser JS, Charboneau JW, Letendre L. Hepatic venocclusive disease after bone-marrow transplantation: diagnosis with duplex sonography. AJR Am J Roentgenol. 1988 Feb; 150(2):289-90.
    View PubMed
  49. Morrison-DeLap SJ, Kuffel DG, Dewald GW, Letendre L. Unbalanced 1;7 translocation and therapy-induced hematologic disorders: a possible relationship. Am J Hematol. 1986 Jan; 21(1):39-47.
    View PubMed
  50. Mailliard JA, Letendre L, Dalton RJ, Levitt R, Gerstner JB, Therneau TM, Pierre RV. Phase I-II trial of VP-16 in the treatment of acute nonlymphocytic leukemia and blast crisis of chronic granulocytic leukemia. Med Pediatr Oncol. 1986; 14(6):306-9.
    View PubMed
  51. Johnson DD, Dewald GW, Pierre RV, Letendre L, Silverstein MN. Deletions of chromosome 13 in malignant hematologic disorders. Cancer Genetics & Cytogenetics. 1985 Nov; 18(3):235-41.
    View PubMed
  52. Moore SB, Motschman TL, Dewald GW, Letendre L, Smithson WA, Hoagland HC. A case of unusually early but temporary humoral immune reconstitution after bone marrow transplantation. Transplantation. 1985 Jun; 39(6):675-7.
    View PubMed
  53. Witzig TE, Ducatman BS, Wick MR, Letendre L, Moore SB, Ilstrup DM, Taswell HF. Platelet transfusion therapy in acute leukemia: lack of effect of splenomegaly on transfusion requirements and risk of hemorrhage. Am J Hematol. 1985 Apr; 18(4):345-50.
    View PubMed
  54. Letendre L, Hinemann V, Hoagland HC, Kovach JS. Phase I study of VP-16 (etoposide) and amsacrine (AMSA) in the treatment of refractory acute leukemia. Medical & Pediatric Oncology. 1985; 13(4):232-4.
    View PubMed
  55. Letendre L, Ludwig J, Perrault J, Smithson WA, Kovach JS. Hepatocellular toxicity during the treatment of refractory acute leukemia with indicine N-oxide. Cancer. 1984 Oct 1; 54(7):1256-9.
    View PubMed
  56. Letendre L, Kiely JM, Hoagland HC. Reinduction chemotherapy for acute nonlymphocytic leukemia. Mayo Clin Proc. 1984 Sep; 59(9):618-21.
    View PubMed
  57. Vaickus L, Letendre L. Pericarditis induced by high-dose cytarabine therapy. Arch Intern Med. 1984 Sep; 144(9):1868-9.
    View PubMed
  58. Letendre L, Kyle RA. Monoclonal cryoglobulinemia with high thermal insolubility. Mayo Clin Proc. 1982 Oct; 57(10):629-33.
    View PubMed
  59. Letendre L, Colgan JP, Hineman VL, Hoagland HC. Treatment of adult acute lymphocytic leukemia. Mayo Clin Proc. 1982 Jul; 57(7):426-30.
    View PubMed
  60. Letendre L, Banks PM, Reese DF, Miller RH, Scanlon PW, Kiely JM. Primary lymphoma of the central nervous system. Cancer. 1982 Mar 1; 49(5):939-43.
    View PubMed
  61. Hoagland HC, Letendre L. Bone marrow transplantation. Mayo Clin Proc. 1981 Mar; 56:204.
  62. Letendre L, Smithson WA, Gilchrist GS, Burgert EO Jr, Hoagland CH, Ames MM, Powis G, Kovach JS. Activity of indicine N-oxide in refractory acute leukemia. Cancer. 1981 Feb 1; 47(3):437-41.
    View PubMed
  63. Edmonson JH, Frytak S, Letendre L, Kvols LK, Eagan RT. Phase II evaluation of dianhydrogalactitol in advanced head and neck carcinomas. Cancer Treat Rep. 1979 Nov-Dec; 63(11-12):2081-3.
    View PubMed